US FDA approves Amneal's self-administered migraine treatment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. SPY
3. EL
4. ADI
5. ROST
6. BILL
7. WMT
8. MRK
9. MRNA
10. MRVL

Go back to US FDA approves Amneal's self-administered migraine treatment
(NASDAQ: AXSM) Delayed: 208.03 -10.17 (4.66%)
Previous Close $218.20    52 Week High $15.74 
Open $216.50    52 Week Low $5.37 
Day High $217.85    P/E N/A 
Day Low $206.26    EPS $0.00 
Volume 559,025